SXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 04.09.14 | Novartis Outperform | BNP PARIBAS | |
| 04.09.14 | Roche buy | UBS AG | |
| 03.09.14 | Novartis Halten | Independent Research GmbH | |
| 02.09.14 | BB Biotech Halten | Independent Research GmbH | |
| 02.09.14 | Novartis overweight | JP Morgan Chase & Co. | |
| 01.09.14 | Novartis buy | UBS AG | |
| 01.09.14 | Novartis Hold | Kepler Cheuvreux | |
| 01.09.14 | Novartis Hold | Deutsche Bank AG | |
| 26.08.14 | Novartis Hold | Kelper Cheuvreux | |
| 26.08.14 | Roche Hold | S&P Capital IQ | |
| 26.08.14 | Roche Outperform | Credit Suisse Group | |
| 26.08.14 | Roche buy | UBS AG | |
| 25.08.14 | Roche buy | Société Générale Group S.A. (SG) | |
| 22.08.14 | Roche buy | UBS AG | |
| 22.08.14 | Novartis Outperform | Credit Suisse Group | |
| 21.08.14 | Novartis buy | Société Générale Group S.A. (SG) | |
| 21.08.14 | Roche buy | Deutsche Bank AG | |
| 21.08.14 | Novartis Hold | Deutsche Bank AG | |
| 19.08.14 | Novartis buy | UBS AG | |
| 19.08.14 | Roche overweight | JP Morgan Chase & Co. | |
| 18.08.14 | Roche buy | UBS AG | |
| 05.08.14 | Roche buy | UBS AG | |
| 05.08.14 | Novartis Hold | Deutsche Bank AG | |
| 29.07.14 | Roche buy | Citigroup Corp. | |
| 29.07.14 | Roche buy | Société Générale Group S.A. (SG) | |
| 25.07.14 | Roche overweight | JP Morgan Chase & Co. | |
| 25.07.14 | Roche overweight | Morgan Stanley | |
| 25.07.14 | Roche Outperform | Bernstein Research | |
| 25.07.14 | Roche buy | Société Générale Group S.A. (SG) | |
| 25.07.14 | Roche overweight | Barclays Capital | |
| 21.07.14 | Novartis Underweight | Morgan Stanley | |
| 21.07.14 | BB Biotech buy | Close Brothers Seydler Research AG | |
| 21.07.14 | Novartis Equal weight | Barclays Capital | |
| 21.07.14 | Novartis overweight | JP Morgan Chase & Co. | |
| 18.07.14 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 18.07.14 | BB Biotech buy | equinet AG | |
| 17.07.14 | Roche buy | UBS AG | |
| 17.07.14 | Roche overweight | Morgan Stanley | |
| 17.07.14 | Novartis buy | S&P Capital IQ | |
| 15.07.14 | Roche Conviction Buy List | Goldman Sachs Group Inc. |